Established in 1994, Current Oncology is a peer-reviewed, Canadian based and Internationally respected journal. Published bi-monthly plus special supplemental issues, Current Oncology represents a multidisciplinary medium encompassing health care workers in the field of cancer therapy to report upon and to review progress in the management of this disease. Current Oncology is published by Multimed Inc.

Current Oncology is indexed/covered in MEDLINE, PubMed, Embase, Scopus, Crossref, Index Copernicus, DOAJ (Directory of Open Access Journals), Google Scholar, EMCare, Research Databases, Science Citation Index Expanded (SciSearch), and Journal Citation Reports/Science Edition. Following publication in Current Oncology, the full text of each article is available immediately and archived in PubMed Central (PMC), the U.S. National Library of Medicine's digital archive of biomedical and life sciences journal literature. It is also available in the databases of 100 libraries worldwide, and is a participant of the HINARI program.

The information provided on the Current Oncology website is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.


WEBEX: Updates in CLL from ASH 2019


Dr. Versha Banerji summarizes key data from practice-changing studies in treatment-naïve chronic lymphocytic leukemia (CLL) from the 61st American Society of Hematology (ASH) Meeting in Orlando, Florida, December 7-10, 2019. Dr. Versha Banerji is a Hematologist and Senior Scientist at CancerCare Manitoba. The Webex can be viewed online at any time using this link.

Funded by AstraZeneca and developed through IMPACT Medicom Inc.

Photo credit: CancerCare Manitoba Foundation

Read more about WEBEX: Updates in CLL from ASH 2019

Soft-tissue Sarcoma Supplement Now Online

Soft-tissue sarcomas have been, until recently, a neglected topic of investigation and publication. This is explained, in comparison with epithelial cancers, by a slower understanding of their pathogenesis and a lack of effective systemic therapies. The past few years, however, have seen changes in their classification, as well as improvements in their treatment, from surgery and radiotherapy to systemic therapy. Our Guest Editor, Dr. Thierry Alcindor (Associate Professor of Oncology & Medicine at McGill University) revisits soft-tissue sarcomas in this special journal issue. Read more about Soft-tissue Sarcoma Supplement Now Online

Current Issue

Published: 2020-05-22


Original Article(s)

Oncologic Pathology

Clinical Trials

Palliative Care

Knowledge Translation

Cancer Control and Prevention

Cancer Genetics

Translational Research

Psychosocial Oncology

Practice Guideline(s)

Case Report(s)

Review Article(s)

Meeting Report(s)

Short Communication(s)